Biohaven Stock Forecast

Stock Price Forecast

According to 19 analysts polled by S&P Global, Biohaven stock has a consensus rating of "Buy" and an average price target of $22. The average 1-year stock price forecast is 48.45% higher than the current stock price, while the lowest is $9.00 (-39.27%) and the highest is $50 (+237.38%).

Price Target: $22 (+48.45%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$9.00	$22	$20	$50
Change	-39.27%	+48.45%	+34.95%	+237.38%

Analyst Ratings

The average analyst rating for Biohaven stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	8	9	9	10	10	10
Buy	4	4	4	4	4	4
Hold	5	5	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	18	18	19	19	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dina Ramadane Bank of America Securities	Bank of America Securities	Sell Downgrades $12 → $11	Sell	Downgrades	$12 → $11	-25.78%	Jun 29, 2026
David Hoang Deutsche Bank	Deutsche Bank	Buy Reiterates $15 → $20	Buy	Reiterates	$15 → $20	+34.95%	Jun 26, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $22	Buy	Maintains	$22	+48.45%	Jun 25, 2026
Christopher Raymond Raymond James	Raymond James	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 25, 2026
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Buy Reiterates $21	Buy	Reiterates	$21	+41.70%	Jun 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

16.76M

EPS This Year

-2.40

from -5.55

EPS Next Year

-1.95

from -2.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-218.90M	-567.93M	-436.05M	-885.11M	-708.37M	-481.12M
Net Income	-213.80M	-570.28M	-408.17M	-846.42M	-738.82M	-470.71M
EPS	-	-	-	-	-5.55	-2.40
Free Cash Flow	-69.94M	-223.44M	-213.77M	-370.97M	-358.12M	-410.87M
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-1.83
Avg	-2.40
Low	-3.05

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-